Pharmaceuticals
Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development
VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biot...
First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment
SUZHOU, China, July 25, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announ...
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 23, 2019 /PRNewswire/ -- In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial. The PIONEER III trial is designed to...
Huge CPhI & P-MEC China a direct result of surging manufacturing
SHANGHAI, July 23, 2019 /PRNewswire/ -- CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, andShanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market inChina continues to gr...
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections
SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US
SUZHOU, China and ROCKVILLE, Md., July 22, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company was notified by the U.S. Food ...
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
INCHEON, South Korea and HONG KONG, July 19, 2019 /PRNewswire/ -- Celltrion and Nan Fung Group announced today the establishment of Vcell Healthcare Limited, a Joint Venture company between both parties. At the formation of the Joint Venture, Vcell Healthcare Limited has simultaneously signed a ...
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
- QuickFire Challenge seeks to identify and accelerate game-changing, early-stage health tech innovations from around the world. - Awardees will receive up to KRW150,000,000 (approximately US $134,000), residence at the Seoul Bio Hub, mentorship and coaching, and access to the Johnson & Johnson...
The Menarini Group Celebrates the Champions of Fair Play
FLORENCE, Italy, July 16, 2019 /PRNewswire/ -- Two days dedicated to sport and the greater values of Fair Play. Last July the city ofFlorence hosted the XXIII^ edition of the International Fair Play Menarini Award: the annual event which celebrates those sporting champions who have stood out in t...
Merck's Embracing Carers™ Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers
DARMSTADT, Germany, July 16, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that its Embracing Carers™ initiative has launched 'Time Counts,' a social media-led video series asking friends and families of carers to collectively give 1 million minutes of thei...
Cipla EU and Jiangsu Acebright Enter Into Joint Venture
MUMBAI & JIANGSU, China, July 16, 2019 /PRNewswire/ -- Cipla (EU) Limited, ("Cipla EU"), a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") and Jiangsu Acebright Pharmaceutical Co. Ltd....
SI Group Announces Focused Sale Of Industrial Resin Business to ASK Chemicals
SCHENECTADY, New York, July 10, 2019 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced today an agreement to sell the majority of its global industrial resin businesses and its B...
Healthcare Startup One BioMed closes US$5M Series A Funding Round
SINGAPORE, July 10, 2019 /PRNewswire/ -- One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced today that it has closed aUS$5 million Series A financing round, led bySingapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore's investment ...
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline
SINGAPORE, July 10, 2019 /PRNewswire/ -- Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capit...
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
MELBOURNE, Australia, July 6, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch ofGene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place duri...
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study
LUND, Sweden, 4 July 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333, NeuroVive's candidate drug for chronic treatment of genetic mitochondri...
Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2019
HONG KONG, July 3, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced the launch of the 2019 Gilead Asia Pacific Rainbow Grant program, a grant initiative that supports community-led programs for people living with HIV in theAsia Pacific region. Non-governmental or advocacy organizations ...
A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer
NEW YORK, July 3, 2019 /PRNewswire/ -- A2A Pharmaceuticals Inc. (A2A), a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents, today announced the appointment of Dr. Sotirios G. Stergiopoulos as President and Chief Executive Officer. He ha...
Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®
SHANGHAI and OSLO, Norway, July 2, 2019 /PRNewswire/ -- Asieris MediTech Co, Ltd (Asieris), aChina-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, and Photocure ASA (Photocure, PHO: OSE), The ...
Dachser India receives IATA CEIV Pharma certification
MUMBAI, India, July 2, 2019 /PRNewswire/ -- The International Airport Transport Association (IATA) recently awarded theMumbai and Hyderabad branches of Dachser India with the prestigious CEIV Pharma certification, recognizing the company for its excellence in transporting Life Science and Healthc...
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 316 media titles]
2024-05-08 14:37OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 308 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 294 media titles]
2024-05-08 16:44